These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29576416)

  • 21. National cancer control plans: a global analysis.
    Romero Y; Trapani D; Johnson S; Tittenbrun Z; Given L; Hohman K; Stevens L; Torode JS; Boniol M; Ilbawi AM
    Lancet Oncol; 2018 Oct; 19(10):e546-e555. PubMed ID: 30268693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health in All Urban Policy: city services through the prism of health.
    Corburn J; Curl S; Arredondo G; Malagon J
    J Urban Health; 2014 Aug; 91(4):623-36. PubMed ID: 25047156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved?
    Schleicher SM; Wood NM; Lee S; Feeley TW
    Oncology (Williston Park); 2016 May; 30(5):468-74. PubMed ID: 27188679
    [No Abstract]   [Full Text] [Related]  

  • 24. Mental health in the context of health disparities.
    Miranda J; McGuire TG; Williams DR; Wang P
    Am J Psychiatry; 2008 Sep; 165(9):1102-8. PubMed ID: 18765491
    [No Abstract]   [Full Text] [Related]  

  • 25. Core elements of national cancer control plans: a tool to support plan development and review.
    Oar A; Moraes FY; Romero Y; Ilbawi A; Yap ML
    Lancet Oncol; 2019 Nov; 20(11):e645-e652. PubMed ID: 31674323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vorwort.
    Hallek M; Bokemeyer C; Lüftner D; Weissinger F
    Oncol Res Treat; 2018; 41 Suppl 3():1. PubMed ID: 30056448
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cancer prevention].
    Sobue T
    Nihon Ronen Igakkai Zasshi; 2006 Jan; 43(1):62-4. PubMed ID: 16521804
    [No Abstract]   [Full Text] [Related]  

  • 28. Policies and practices in the health-related reception of quota refugees in Denmark.
    Frederiksen HW; Krasnik A; Nørredam M
    Dan Med J; 2012 Jan; 59(1):A4352. PubMed ID: 22239837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of patient choice of provider on equity: analysis of a patient survey.
    Robertson R; Burge P
    J Health Serv Res Policy; 2011 Apr; 16 Suppl 1():22-8. PubMed ID: 21460346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A limitation to equal access in clinical trials: the Medicare review process.
    King SB; Kandzari DE
    JACC Cardiovasc Interv; 2013 Jun; 6(6):640-1. PubMed ID: 23787242
    [No Abstract]   [Full Text] [Related]  

  • 31. Disparities In Cancer Care And Costs At The End Of Life: Evidence From England's National Health Service.
    Walsh B; Laudicella M
    Health Aff (Millwood); 2017 Jul; 36(7):1218-1226. PubMed ID: 28679808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers.
    Pearson AD; Heenen D; Kearns PR; Goeres A; Marshall LV; Blanc P; Vassal G
    Lancet Oncol; 2018 Mar; 19(3):285-287. PubMed ID: 29508745
    [No Abstract]   [Full Text] [Related]  

  • 34. Oncology pharmaceutical funding in New Zealand: a different approach and a proposal.
    Beatty PA; Laking GR
    J Oncol Pract; 2015 May; 11(3):249-51. PubMed ID: 25829524
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cancer Plan 3 and molecular pathology: serendipity in pathology?].
    Sabourin JC
    Ann Pathol; 2014 Aug; 34(4):253-4. PubMed ID: 25132433
    [No Abstract]   [Full Text] [Related]  

  • 36. Canadians want national medical standards to prevent inequalities.
    Kermode-Scott B
    BMJ; 2012 Jan; 344():e520. PubMed ID: 22267655
    [No Abstract]   [Full Text] [Related]  

  • 37. Health inequalities and France's national health strategy.
    Touraine M
    Lancet; 2014 Mar; 383(9923):1101-2. PubMed ID: 24679616
    [No Abstract]   [Full Text] [Related]  

  • 38. Regulatory barriers to clinical trial enrollment of adolescent and young adult oncology patients.
    Felgenhauer J; Hooke MC
    Pediatrics; 2014 Jun; 133 Suppl 3():S119-22. PubMed ID: 24918210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [National health plan cancer 3 is about reducing inequalities].
    Warnet S
    Rev Infirm; 2014 Mar; (199):8. PubMed ID: 24754114
    [No Abstract]   [Full Text] [Related]  

  • 40. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
    Robson ME; Storm CD; Weitzel J; Wollins DS; Offit K;
    J Clin Oncol; 2010 Feb; 28(5):893-901. PubMed ID: 20065170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.